POMA AI Achieves Best-in-Class RAG Chunking and Document Ingestion With 77% Token Reduction vs. Conventional Models 
Bonus Savings Account: What It Is and How It Helps You Earn More Interest Intel Highlights 2022 and Long-Term Growth Strategy at Investor Meeting
Intel details plans to lead in traditional markets, disrupt high-growth emerging markets. SAN FRANCISCO–(BUSINESS WIRE)–Intel…
Modular Devices Holdings, LLC Expands Executive Team, Hires Sarah Robison as Chief Financial Officer
INDIANAPOLIS–(BUSINESS WIRE)–Modular Devices Holdings, LLC (“Modular Devices”), a leading provider of mobile and modular medical…
BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
New board members bring a wealth of financial, strategy and global health expertise NORTH BRUNSWICK,…
Galecto Reports Financial Results for the Year Ended December 31, 2021
Continued pipeline progress with three potentially first-in-class product candidates Strong cash position with cash runway…
Orion’s collaboration partner Bayer upgrades estimate on Nubeqa®’s peak sales potential
ORION CORPORATION INSIDE INFORMATION / STOCK EXCHANGE RELEASE 17 FEBRUARY 2022 at 23.32 EET Orion’s…
Darolutamide plus androgen deprivation therapy and docetaxel significantly increases overall survival in patients with metastatic hormone-sensitive prostate cancer
ORION CORPORATION PRESS RELEASE17 FEBRUARY 2022 at 23.32 EET Darolutamide plus androgen deprivation therapy and docetaxel…
Cronos Group Inc. to Hold 2021 Third Quarter Earnings Conference Call on February 18, 2022
TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
Ms. Jones, a veteran of the biotechnology and pharmaceutical industries, has served as an Executive Officer…
Genesis Unicorn Capital Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
Princeton, NJ, Feb. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Genesis Unicorn Capital Corp. (the “Company”)…
Shockwave Medical Reports Fourth Quarter and Full Year 2021 Financial Results
SANTA CLARA, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
Full Year 2021 Total Revenue Growth of 55%; Plans to Double Sepsis Revenue and T2Dx…
Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
CANTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Bioasis Announces $200,000 Non-Brokered Private Placement
NEW HAVEN, Conn., Feb. 17, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Converge Technology Solutions Reports Strong Preliminary Q4-2021 Results
TORONTO and GATINEAU, Québec, Feb. 17, 2022 (GLOBE NEWSWIRE) — Converge Technology Solutions Corp. (“Converge”…
BitZERO Announces Kevin O’Leary and Phoenix Group as Strategic Investors
Vancouver, British Columbia–(Newsfile Corp. – February 17, 2022) – BitZERO Blockchain Inc. (“BitZERO” or the…
Coherus BioSciences Reports Fourth Quarter and Full Year 2021 Results
– YUSIMRY™ (adalimumab-aqvh), Coherus’ second product, approved by FDA on December 17, 2021 –– BLAs…
MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd
NEWS RELEASE 17 February 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present Fourth…
Agios Announces FDA Approval of PYRUKYND® (mitapivat) as First Disease-Modifying Therapy for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
Kim Hall Kim Hall, Living with PK Deficiency – Approval Based on Results from ACTIVATE…
Sorrento Announces That It Has Acquired a Majority Ownership in Diagnostic Manufacturer Zhengzhou Fortune Bioscience in Response to Increasing Worldwide Demand For COVISTIX™
COVISTIX is a highly sensitive and rapid antigen detection test for SARS-CoV-2 and its major…